The GLP is committed to full transparency. Download and review our 2019 Annual Report

First large scale trial of whole-genome cancer testing for clinical decision-making

| October 3, 2012
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

For the first time, researchers have conducted a large trial in which they tested the entire genome of individual breast cancers to help personalize treatment. They released their findings at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

In recent years, a number of drugs have been developed that target specific genetic alterations in cancer. To choose which of these drugs are suitable for individual patients, some genetic testing is performed. “In most of these cases, these genetic testing approaches only analyze a limited number of genes,” said study author Dr Fabrice André from Institute Gustave Roussy, Villejuif, France.

View the original article here: First large scale trial of whole-genome cancer testing for clinical decision … – Science Codex

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend